airmid healthgroup BLOG

latest news and science updates from airmid healthgroup

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Tags
    Tags Displays a list of tags that have been used in the blog.

airmid continues its unique publication series in indoor aerobiology and health.

Posted by on in airmid healthgroup BLOG
  • Font size: Larger Smaller
  • Hits: 2610
  • Subscribe to this entry
  • Print

It’s the time of year again for the American Academy of Asthma Allergy and Immunology (AAAAI) Annual Meeting in San Antonio Texas (February 22-26). The meeting will be attended by more than 7,700 allergist/immunologists, related physicians, and industry representatives.

Following on from our presentation at the meeting last year, the airmid research team will again be travelling to the USA to present biomedical research data related to indoor air quality and health. The exciting research which is sure to stimulate some interesting debate is embargoed until after it has been presented. We will however be making some of the details public after the event.

The analysis of the samples again utilized the airmid allergen analysis facility, the only one of its type in the world with ISO 17025 accreditation. As a world leading biomedical research organisation, airmid help clients across a number of sectors improve, add value and differentiate their customer offerings through a focus on biomedical data, health impact claims and air quality.

Presenting at another prestigious American meeting marks the latest instalment in a series of studies we conducted related to carpet and a healthy indoor environment. Related presentations includes those at the American Academy of Asthma, Allergy, and Immunology (AAAAI) conference in March 2012 and the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in November 2012.

The airmid value proposition is based in the fact that we are in the business of results. We are not only judged on our scientific excellence but also our valued added marketing particularly as it relates to health based claims. For example we advise on biomedical labelling, press releases and copywriting for content. A steady stream of publications, patents and R and D projects is fundamental to our mission and aligned with our goals of licensing and technology transfer.

If you would like to learn more about how airmid can assist your research capabilities, generate data and most importantly convert it into value please contact Graeme Tarbox gtarbox@airmidhealthgroup.com

About airmid healthgroup
We help our clients across a number of sectors improve, add value and differentiate their customer offerings through a focus on biomedical data, health impact claims and air quality. We have a uniquely integrated facility which combines molecular biology and state-of-the-art air sampling in a highly developed environmental test chamber, where we can follow nominated allergens, viruses, bacteria, molds or other ultra-fine particles. As a world leading biomedical and aerobiology research facility our clients describe us as a specialised extension to their research capabilities, we capture, store and manage your data and most importantly convert it into value.

Related testing
http://www.airmidhealthgroup.com/industries-served/floor-coverings.html
http://www.airmidhealthgroup.com/services/contract-research.html